Healthcare -
Biotechnology - NASDAQ - US
$ 422.0
1.21 %
$ 109 B
Market Cap
-219.79
P/E
VRTX - STOCK-BASED COMPENSATION
Stock-based Compensation VRTX - Vertex Pharmaceuticals Incorporated
581 M
LAST VALUE
14.75%
2 YEAR CAGR
12.32%
5 YEAR CAGR
16.40%
10 YEAR CAGR